Reportlinker Adds the Market for Prescription Dermatological Drugs, 7th Edition
NEW YORK, Dec. 7, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Market for Prescription Dermatological Drugs, 7th Edition
This Kalorama Information report details the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future. The global market for prescription dermatology drugs includes products in the following categories:
- Prescription Acne and Rosacea Drugs
- Prescription Antiaging and Photodamage Drugs
- Prescription Dermatitis and Seborrhea Drugs
- Prescription Fungal Infection Drugs
- Prescription Hair Loss and Hair Removal Drugs
- Prescription Hyperpigmentation/Melasma Drugs
- Prescription Psoriasis Drugs
- Prescription Skin Cancer Drugs
- Other Prescription Skin Disorder Drugs
The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products. Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities. By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology. This transition will play a role in the future development of the dermatological industry over the forecast period. The global pharmaceutical sector has little choice but to continue expanding through mergers and acquisitions for some time to come. It's a very dynamic time for the industry focusing on a worldwide market, and among the trends covered in this report are:
- Patient Compliance
- Cosmetic Dermatologists
- Melanoma Survival Rates Falter
- Phosphatidylglycerol and Psoriasis
- New Itch Gene Found
- New Filler Options
- Consumer Confusion
- Genetic Link to Psoriasis
- Biologic Dermatology
- Rx-to-OTC Switches
- Cosmeceuticals
- Antioxidants
- Polypeptides
- Teledermatology
- Reimbursement Issues
- Accutane IPledge Program
- Laser Therapy
- Narrowband Ultraviolet B
- Photodynamic Therapy
- New Oral Medications and Research for Acne
- Synthetic Lipids for Skin Healing
- Importance of Drug Delivery
The information and analysis presented in this report are based on extensive interviews with senior management of top companies in the dermatology market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 42 industry executives and product managers to validate and obtain expert opinion on current and future trends in the dermatological market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.
The following companies are profiled in this report:
- Allergan Inc.
- Allergan Inamed Corporation
- Barrier Therapeutics, Inc
- Bayer AG
- PharmaDerm Pharmaceuticals, Inc
- Bristol-Myers Squibb
- Collagenex (now Galderma) Pharmaceuticals
- Galderma S.A.
- Genentech, Inc.
- GlaxoSmithKline Plc
- Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
- Medicis Pharmaceutical Corporation
- Merck & Company, Inc.
- Mylan Pharmaceuticals, Inc,
- Novartis Pharmaceuticals Corporation
- Nycomed Inc.
- Pfizer, Inc.
- Q-Med AB
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering (now Merck)-Plough Corporation
- Sinclair Pharma Plc.
- SkinMedica
- Stiefel Laboratories, Inc.
- Valeant Pharmaceuticals, Inc.
All market data pertains to the global market at the manufacturers' level. Data are expressed in current U.S. dollars. The base year for data was 2009. Historical data are provided for each of the years 2007 to 2009, and forecast data are provided for each of the years 2009 through 2014. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2009 base year.
CHAPTER ONE: EXECUTIVE SUMMARY
Introduction
Scope and Methodology
Size and Growth of the Market
Issues and Trends Affecting Market
Competitor Analysis
CHAPTER TWO: INTRODUCTION
Structure and Function of the Skin
Epidermis
Dermis
Subcutaneous Tissue
Epidermal Appendages
Functions of the Skin
Effects of Aging on the Skin
Dermatological Conditions and Treatment
Pharmacokinetics
Drug Absorption
Distribution
Bioavailability
Drug Delivery Methods
Demographics of Skin Disorders, Incidence, and Prevalence
CHAPTER THREE: ISSUES AND TRENDS
Patient Compliance
Cosmetic Dermatologists
Melanoma Survival Rates Falter
Phosphatidylglycerol and Psoriasis
New Itch Gene Found
New Filler Options
Consumer Confusion
Genetic Link to Psoriasis
Biologic Dermatology
Rx-to-OTC Switches
Cosmeceuticals
Antioxidants
Polypeptides
Teledermatology
Reimbursement Issues
Accutane IPledge Program
Laser Therapy
Narrowband Ultraviolet B
Photodynamic Therapy
New Oral Medications and Research for Acne
Synthetic Lipids for Skin Healing
Importance of Drug Delivery
CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS
Description of Disorders
Description of Products
Benzoyl Peroxide
Description of Products
Current Suppliers
Retinoids
Topical Formulations
Systemic Formulations
Current Suppliers
Antibiotics
Description of Products
Current Suppliers
Oral Contraceptives
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS
Overview
Description of Products
Keratolytics
Moisturizers
Retinoids
Sunscreens
Other Agents
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS
Overview
Description of Products
Topical Corticosteroids
Systemic Corticosteroids
Other Products
Research and Development
Market Size and Growth
Global Market by Type
Markets by Geographical Region
United States
Europe
Japan
Rest of World
Future of the Market
Competitive Analysis
CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS
Overview
Description of Products
Systemic Formulations
Terbinafine
Itraconazole
Fluconazole
Griseofulvin
Ketoconazole
Current Suppliers
Topical Formulations
Polyenes
Azoles
Allylamines and Benzylamines
Other Topical Formulations
New Products
Current Suppliers
Research and Development
Market Size and Growth
Global Market by Type
Markets by Geographical Region
United States
Europe
Japan
Rest of World
Future of the Market
Competitive Analysis
CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS
Overview
Description of Products
Antiandrogens
Androgen Inhibitors
Oral Contraceptives
Other Treatments
Research and Development
Market Size and Growth
Global Market by Type
Markets by Geographical Region
United States
Europe
Japan
Rest of World
Future of the Market
Competitive Analysis
CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION / MELASMA DRUGS
Overview
Description of Products
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS
Overview
Description of Products
Topical Psoriasis Products
Anthralin
Coal Tar
Methoxsalen
Second-generation Retinoids
Tazarotene
Topical Vitamin D
Vitamin D Analogs
Vanos
Systemic Psoriasis Preparations
Betamethasone
Cortisone Acetate
Cyclosporine
Hydrocortisone
Methotrexate
Olopatadine Hydrochloride
Tacrolimus
Light Therapy
Biologics
Research and Development
Market Size and Growth
Global Market by Type
Markets by Geographical Region
United States
Europe
Japan
Rest of World
Future of the Market
Competitive Analysis
CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS
Overview
Nonmelanoma Skin Cancers
Actinic Keratoses
Basal Cell Carcinoma
Squamous Cell Carcinoma
Cutaneous T-cell Lymphoma
Dysplastic Nevus Syndrome
Malignant Melanoma
Description of Products
5-Fluorouracil
Mechlorethamine/Nitrogen Mustard
Carmustine/BCNU (Topical)
Vinblastine (Intralesional) and Others
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS—ANTIVIRALS AND ANTIPARASITICS
Overview
Antivirals
Antiparasitics
Description of Products
Topical Antivirals
Antiviral Drugs
Immunoenhancing Drugs
Current Suppliers
Antiparasitic Agents
Current Suppliers
Other Skin Related Products
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER THIRTEEN: WORLD MARKET SUMMARY
Overview
Total Market Size and Forecast
Market and Competitive Analysis
CHAPTER FOURTEEN: CORPORATE PROFILES
Allergan Inc
Allergan Inamed Corporation
Barrier Therapeutics, Inc
Bayer AG
PharmaDerm Pharmaceuticals, Inc
Bristol-Myers Squibb
Collagenex (now Galderma) Pharmaceuticals
Galderma S.A
Genentech, Inc
GlaxoSmithKline Plc
Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
Medicis Pharmaceutical Corporation
Merck & Company, Inc
Mylan Pharmaceuticals, Inc,
Novartis Pharmaceuticals Corporation
Nycomed Inc
Pfizer, Inc
Q-Med AB
Roche Group (F. Hoffmann-La Roche Ltd.)
Schering (now Merck)-Plough Corporation
Sinclair Pharma Plc
SkinMedica
Stiefel Laboratories, Inc
Valeant Pharmaceuticals, Inc
APPENDIX: Company Directory
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: The Global Market for Prescription Dermatological Drugs 2001, 2006, and 2011
Figure 1-1: The Global Market for Prescription Dermatological Drugs 2001, 2006, and 2011
CHAPTER TWO: INTRODUCTION
Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions
Chapter three: Issues and Trends
Table 3-1: Selected Dermatological Rx-to-OTC Switches
CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS
Table 4-1: Common Benzoyl Peroxide Formulations
Table 4-2: Common Retinoid Formulations
Table 4-3: Common Antibiotic Formulations
Table 4-4: Common Oral Contraceptive Formulations
Table 4-5: Prescription Acne, Actinic Keratosis and Rosacea Formulations in Development
Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by Type 2001-2011
Figure 4-1: The Global Market for Prescription Acne and Rosacea Drug Revenues by Type, 2001-2011 70
Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2006
Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2011
Table 4-7: The Global Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 2001-2011
Figure 4-4: The Global Market for Prescription Antiacne and Rosacea Drugs Revenues by Geographical Region 2001-2011
Figure 4-5: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2006
Figure 4-6: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2011
Table 4-8: Global Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2006
Figure 4-7: Global Market for Acne and Rosacea Drugs Market Share by Leading Supplier 2006
CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS
Table 5-1: Common Prescription Keratolytic Formulations
Table 5-2: Occlusive Moisturizers—Categories of Ingredients
Table 5-3: Common Prescription Moisturizers
Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
Table 5-5: Common Prescription Sunscreens
Table 5-6: Other Prescription Antiaging and Photodamage Products
Table 5-7: Prescription Antiaging and Photodamage Formulations in Development
Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type 2001-2011
Figure 5-1: The Global Market for Antiaging and Photodamage Drugs Revenues by Type 2001-2011
Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share by Type 2006
Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share by Type 2011
Table 5-9: The Global Market for Prescription Antiaging and Photodamage |Drugs by Geographical Region 2001-2011
Figure 5-4: The Global Market for Prescription Antiaging and Photodamage Drugs, Revenues by Geographical Region 2001-2011
Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2006
Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2011
Table 5-10: Global Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2006
Figure 5-7: Global Market for Prescription Antiaging and Photodamage Drugs, Market Share by Leading Supplier 2006
CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS
Table 6-1: Common Prescription Topical Corticosteroid Preparations
Table 6-2 Common Prescription Systemic Corticosteroids
Table 6-3: Prescription Other Dermatitis Formulations
Table 6-4: Prescription Dermatitis Formulations in Development
Table 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Type 2001-2011
Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Type 2001-2011
Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2006
Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2011
Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Geographical Region 2001-2011
Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Geographical Region 2001-2011
Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2006
Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2011
Table 6-7: Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues and Market Share by Supplier 2006
Figure 6-7: Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Leading Supplier 2006
CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS
Table 7-1: Common Prescription Systemic Antifungal Dermatological Formulations
Table 7-2: Common Prescription Topical Antifungal Dermatological Drugs
Table 7-3: Prescription Antifungal Dermatological Drugs in Development
Table 7-4: The Global Market for Prescription Antifungal Dermatological Drugs by Type 2001-2011 152
Figure 7-1: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Type 2001-2010
Figure 7-2: The Global Market for Prescription Antifungal Dermatological Drugs Share by Type 2006 154
Figure 7-3: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2011
Table 7-5: The Global Market for Prescription Antifungal Dermatological Drugs by Geographical Region 2001-2011
Figure 7-4: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Geographical Region 2001-2011
Figure 7-5: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2006
Figure 7-6: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2011
Table 7-6: Global Market for Prescription Antifungal Dermatological Drugs Revenues and Market Share by Supplier 2006
Figure 7-7: Global Market for Prescription Antifungal Dermatological Drugs Market Share by Leading Supplier 2006
CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS
Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
Table 8-2: Prescription Hair Loss or Hair Removal Formulations in Development 170
Table 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs by Type 2001-2011
Figure 8-1: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Type 2001-2011
Figure 8-2: The Global Market for Prescription Hair Loss and Hair Removal Drugs, Share by Type 2006
Figure 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs, Share by Type 2011
Table 8-4: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Geographical Region 2001-2011
Figure 8-4: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Geographical Region 2001-2011
Figure 8-5: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Geographical Region 2006
Figure 8-6: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Geographical Region 2011
Table 8-5: Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2006
Figure 8-7: Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Leading Supplier 2006
CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION/MELASMA DRUGS
Table 9-1: Common Prescription Hyperpigmentation/Melasma Formulations
Table 9-2: Common Prescription Depigmenting Agents
Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type 2001-2011
Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs Revenues by Type 2001-2011
Figure 9-2: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Type 2006
Figure 9-3: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Share by Type 2011
Table 9-4: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs by Geographical Region 2001-2011
Figure 9-4: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Revenues by Geographical Region 2001-2011
Figure 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2006
Figure 9-6: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2011
CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS
Table 10-1: Common Prescription Psoriasis Preparations
Table 10-2: Prescription Psoriasis Preparations in Development
Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type 2001-2011
Figure 10-1: The Global Market for Prescription Psoriasis Drugs Revenues by Type 2001-2011
Figure 10-2: The Global Market for Prescription Psoriasis Drugs Share by Type 2006
Figure 10-3: The Global Market for Prescription Psoriasis Drugs Share by Type 2011
Table 10-4: The Global Market for Prescription Psoriasis Drugs by Geographical Region 2001-2011 227
Figure 10-4:The Global Market for Prescription Psoriasis Drugs Revenues by Geographical Region 2001-2011
Figure 10-5: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2006
Figure 10-6: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2011
Table 10-5: Global Market for Prescription Psoriasis Drugs Revenues and Market Share by Supplier 2006 231
Figure 10-7: Global Market for Prescription Psoriasis Drugs Market Share by Leading Supplier 2006 231
CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS
Table 11-1: Malignant Conditions of the Skin
Table 11-2: Common Prescription Topical and Intralesional Chemotherapeutic Agents
Table 11-3: Prescription Skin Cancer Preparations in Development
Table 11-4: The Global Market for Skin Cancer Drugs 2001-2011
Figure 11-1: The Global Market for Skin Cancer Drugs 2001-2011
Table 11-5: The Global Market for Prescription Skin Cancer Drugs by Geographical Region 2001-2011 247
Figure 11-2: The Global Market for Prescription Skin Cancer Drugs Revenues by Geographical Region 2001-2011
Figure 11-3: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2006
Figure 11-4: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2011
Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2006
Figure 11-5: Global Market for Skin Cancer Drugs Market Share by Leading Supplier 2006
CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS --ANTIVIRALS AND ANTIPARASITICS
Table 12-1: Common Prescription Topical Antiviral Formulations
Table 12-2: Common Prescription Topical Antiparasitic Formulations
Table 12-3: Prescription Miscellaneous Skin Preparations in Development
Table 12-4: The Global Market for Prescription Miscellaneous Skin Disorder Drugs by Type 2001-2011
Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs | Revenues by Type 2001-2011
Figure 12-2: The Global Market for Miscellaneous Skin Disorder Drugs Share by Type 2006
Figure 12-3: The Global Market for Miscellaneous Skin Disorder Drugs Share by Type 2011
Table 12-6: The Global Market for Prescription Miscellaneous Drugs by Geographical Region 2001-2011 268
Figure 12-4: The Global Market for Prescription Miscellaneous Drugs Revenues by Geographical Region 2001-2011
Figure 12-5: The Global Market for Prescription Miscellaneous Drugs .. Share by Geographical Region 2006
Figure 12-6: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2011
CHAPTER THIRTEEN: WORLD MARKET SUMMARY
Table 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Segment, 2001-2011
Figure 13-1: The Global Market for Prescription Dermatological Drugs Revenues by Dermatological Segment 2001-2011
Figure 13-2: The Global Market for Dermatological Drugs Market Share by Type 2006
Figure 13-3: The Global Market for Dermatological Drugs Market Share by Type 2011
Table 13-3: Global Market for Prescription Dermatological Drugs Revenues and Segments of Participation by Leading Market Participants 2006
To order this report:
Prescription Drug Industry: The Market for Prescription Dermatological Drugs, 7th Edition
Prescription Drug Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article